SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-21-004544
Filing Date
2021-06-28
Accepted
2021-06-28 08:00:26
Documents
26
Period of Report
2021-06-26
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_062621.htm   iXBRL 8-K 15036
2 PRESS RELEASE exh_991.htm EX-99.1 25697
3 EXHIBIT 99.2 exh_992.htm EX-99.2 17222
4 exh992_01.jpg GRAPHIC 43465
5 exh992_02.jpg GRAPHIC 124725
6 exh992_03.jpg GRAPHIC 75266
7 exh992_04.jpg GRAPHIC 72747
8 exh992_05.jpg GRAPHIC 108356
9 exh992_06.jpg GRAPHIC 76879
10 exh992_07.jpg GRAPHIC 89216
11 exh992_08.jpg GRAPHIC 74733
12 exh992_09.jpg GRAPHIC 70212
13 exh992_10.jpg GRAPHIC 53303
14 exh992_11.jpg GRAPHIC 52918
  Complete submission text file 0001171843-21-004544.txt   1430387

Data Files

Seq Description Document Type Size
15 XBRL SCHEMA FILE gnw-20190101.xsd EX-101.SCH 3069
16 XBRL DEFINITION FILE gnw-20190101_def.xml EX-101.DEF 25640
17 XBRL LABEL FILE gnw-20190101_lab.xml EX-101.LAB 34011
18 XBRL PRESENTATION FILE gnw-20190101_pre.xml EX-101.PRE 22139
19 EXTRACTED XBRL INSTANCE DOCUMENT f8k_062621_htm.xml XML 3026
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34949 | Film No.: 211049990
SIC: 2834 Pharmaceutical Preparations